Moreover, we also documented that a doubling in serum YKL-40 and 4th quartile YKL-40 values were associated with a 16% respectively 63% increased risk of first-time stroke, which are in accordance with findings in the Copenhagen City Heart Study [8]. This evidence concerns the gene CHI3L1 and stroke disorder.